Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs

Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - July/August 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Podcasts
    • Thought leadership
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2025
    • Symposium 2024
    • Symposium 2023
    • Symposium 2022
    • Symposium 2021
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs

  • Regulatory Rapporteur - July/August 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • AdobeStock_2031070488_main image
      Drug development and regulatory pathways across therapeutic areas
    • AdobeStock_230080191_main image
      Navigating the regulatory landscape of adverse events following immunisation: Current challenges and future perspectives
    • AdobeStock_1057710391_main image
      The development of novel influenza drugs: Current regulatory challenges
  • Veterinary
    • VET main image
      A career in veterinary regulatory affairs: Roles and competencies across the product lifecycle
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • 1. image 1 same image in previous MedDev updates
      Medical device standards update: July 2026
    • AdobeStock_1357495965
      Medical Device Regulation 2.0: Why stakeholder disagreement is bad for all
    • GATEKEEPER main image
      From gatekeepers to collaborators: Regulatory evolution toward risk-based lifecycle approaches in an era of innovation
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • EU AI Act Image
      European Commission targets high-risk AI with new draft guidelines
    • AdobeStock_797781580
      The HMA-EMA NDSG publishes report on AI in medicines development
    • AdobeStock_1881391431
      MHRA releases AI Airlock Phase 2 programme report
  • Commentary
      • Editorials
      • Podcasts
      • Thought leadership
      • Letters to the Editor
    • cover image
      Therapeutics: Navigating diverse regulatory pathways
    • Main image
      Lifecycle management: Enhancing regulatory agility
    • cover image
      The regulatory profession: Origins, career development and the road ahead
  • Collections
      • Interviews
      • Symposium 2025
      • Symposium 2024
      • Symposium 2023
      • Symposium 2022
      • Symposium 2021
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Medical devices

November 2025 – Contents: Medical devices/IVD sessions

  • No comments
 

Write to the Editor at publications@topra.org

 

Margareth Jorvid

HM5/MD1/IVD1: Programme COMBINE – Accelerating clinical trials and medical innovation in the EU

By Nathalie Boeglin

 

Ulf Schriever

MD2/IVD2: Clinical investigation with medical devices

By Charlotte Holleran

 

MD3/IVD3: A global snapshot – Non-EU regulatory updates for medical devices and IVDs

By Célia Cruz

 

Natasha Bankowski_MD4 IVD4

MD4/IVD4: Bridging the gaps – Developments in medical device and IVD regulatory harmonisation

By Erica Cypas

 

Alex Laan

IVD5: Navigating conformity assessment for IVDs – Challenges and opportunities

By Natasha Bankowski

 

Ashleigh Batchen

MD5: The evolution of the EU Medical Device Regulation

By Célia Cruz

 

Ashleigh Batchen and Steffen Luckner

IVD6: The evolution of the In Vitro Diagnostic Regulation

By Hasnaa Fatehi

 

Wolfgang Lauer, Henrik Emmert and Holly Coole_MD6

MD6: The importance of digital health – Digital Health Applications (DiGA) and Digital Mental Health Technology Project

By Steve Lee

 

Alex Laan_IVD7

IVD7: EU reference laboratories under the IVDR – One year on

By Claire McDonald

 

Felicity Ellis

MD7: Updates on Artificial Intelligence legislation and policy

By Hasnaa Fatehi

 

Antonella Lombardi and Carlos Galamba

IVD8: The hunt for evidence – An IVD perspective

By Margareth Jorvid

 

Nikhil Khadabadi__MD8

MD8: Post-market challenges for medical devices

By Rachel Drapela

 

Topics

  • Advanced therapy medicinal products (ATMPs)
  • Artificial intelligence (AI)
  • Chemistry, manufacturing and controls (CMC)
  • Clinical trial
  • COMBINE
  • Electronic product information (ePI)
  • EU general pharmaceutical legislation (GPL)
  • EU HTA Regulation
  • European Medicines Agency (EMA)
  • Medical Devices
  • No comments

More from Medical devices

  • SAFETY- main image
    Journal

    Enhancing post-market surveillance with Artificial Intelligence and predictive analytics

    2026-06-09T08:30:00Z

    By Harish Gyanaji and Murali Krishna Tirunagari

  • GATEKEEPER main image
    Journal

    From gatekeepers to collaborators: Regulatory evolution toward risk-based lifecycle approaches in an era of innovation

    2026-06-02T09:15:00Z

    By Attrayee Chakraborty and Geethapriya (Priya) Setty

  • RECRUIT main image
    Journal

    Career growth in medical device regulatory affairs: A recruiter's perspective

    2026-05-05T14:57:00Z

    By Nathan Puxty

  • DEVICE main image
    Journal

    An accidental profession: Finding your path in medical device regulatory affairs

    2026-05-05T14:35:00Z

    By Jack Bacon

  • ACADEMIC main image
    Journal

    Bridging science and compliance: A career path from academia to regulatory medical writing

    2026-04-30T15:20:00Z

    By Megan Allen

  • LEAN-main image
    Journal

    Lean Six Sigma in post-market surveillance: Insights for EU 2017/745 MDR Article 88 and Great Britain SI 2024/1368 (44ZN) trend reporting compliance

    2026-04-09T16:06:00Z

    By Harish Gyanaji and Venkata Sai Niharika Dommeti

Related articles

  • EC med devices news story
    Industry news

    EC proposes regulation to simplify rules on medical and in vitro diagnostic devices

    2025-12-22T12:46:00Z

    By Jack Bacon

  • Half cover_final
    Contents

    Regulatory Rapporteur July/August 2026 – Contents

  • 1. image 1 same image in previous MedDev updates
    Journal

    Medical device standards update: July 2026

    2026-07-01T15:25:00Z

    By Charlotte Holleran

  • AdobeStock_1357495965
    Commentary

    Medical Device Regulation 2.0: Why stakeholder disagreement is bad for all

    2026-06-29T11:16:00Z

    By John Wilkinson OBE

  • EU AI Act Image
    Industry news

    European Commission targets high-risk AI with new draft guidelines

    2026-06-25T15:03:00Z

    By James Smith

  • AdobeStock_797781580
    Industry news

    The HMA-EMA NDSG publishes report on AI in medicines development

    2026-06-19T14:27:00Z

    By James Smith

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud